Molecular mechanisms of autoimmunity
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis in Autoimmunity
- Vol. 41 (2) , 123-132
- https://doi.org/10.1080/08916930801929021
Abstract
Autoimmunity is mediated by a variety of mechanisms, molecular and cellular events, and responses. Predisposition to a given autoimmune response requires the requisite allele(s) that controls antigen presentation by antigen-presenting cells for T cell recognition. Some autoimmune responses emerge following infection by a pathogen, whose protein(s) possess structural similarities in some of its epitopes to regions on proteins of the host. Thus, antibodies evoked against a pathogen might cross-react with a self-protein and act as autoantibodies, and the involved autoantigen then provides a source for persistent stimulation. Proteins to which the immune system is ordinarily self-tolerant might, if altered, elicit autoimmune responses. Ways in which self-proteins can be altered include mutations and altered expression, posttranslational modification, covalent modifications, denaturation, native disorder or misfolding. Sequestered proteins normally sheltered from immune recognition become immunogenic and targets of immune effector functions, once exposed to the immune system. Other alterations can occur because of disruption in the levels or activity of regulatory proteins. These include certain alleles of the cytotoxic T lymphocyte-associated antigen-4 gene (possibly a nonspecific exacerbating molecule of disease risk in several autoimmune diseases), the lymphoid protein tyrosine phosphatase nonreceptor type 22 gene (associated with type 1 diabetes and other autoimmune diseases), TNF-alpha (involved in chronic inflammation, autoimmunity and malignancies) and the FOXP3 gene (expressed by CD4+C25+ regulatory T cells), whose mutations can cause immune dysregulation, polyendocrinopathy and X-linked inheritance syndromes of systemic autoimmunity. An autoimmune response can also arise from natural antibodies or autoantibodies that occur independently of known immunization and are able to bind to microbial antigens, altered proteins as well as self-antigens. Natural autoantibodies possess in general a low intrinsic affinity for antigen, but can function as templates for the generation of pathogenic autoantibodies, that emerge through a process of clonal selection entailing somatic hypermutation and class switch DNA recombination, as driven by antigen.Keywords
This publication has 131 references indexed in Scilit:
- Apoptosis in the pathophysiology of diabetes mellitusThe International Journal of Biochemistry & Cell Biology, 2007
- Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal diseaseClinical and Experimental Immunology, 2007
- Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experienceGut, 2007
- The Broad Antibacterial Activity of the Natural Antibody Repertoire Is Due to Polyreactive AntibodiesCell Host & Microbe, 2007
- A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 geneDiabetologia, 2007
- Linkage proof for PTPN22 , a rheumatoid arthritis susceptibility gene and a human autoimmunity geneProceedings of the National Academy of Sciences, 2007
- PTPN22: Its role in SLE and autoimmunityAutoimmunity, 2007
- Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing lossClinical and Experimental Immunology, 2006
- Autoimmunity versus tolerance: Can dying cells tip the balance?Clinical Immunology, 2006
- Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of myasthenia gravis?Human Immunology, 2000